STAINES-UPON-THAMES, United Kingdom, Nov. 8, 2018 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has received the ...
Mallinckrodt plc, a global specialty pharmaceutical company, announced that the INOmax EVOLVE DS delivery system has been cleared by the US Food and Drug Administration (FDA) for the delivery of ...
– Company's next generation nitric oxide delivery system combines mini-cylinder technology, automation, integration, and interaction into one device 1 – – The INOmax EVOLVE DS also earned recognition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback